• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有鼻息肉的慢性鼻-鼻窦炎患者生活质量的分子和临床预测指标

Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps.

作者信息

Brunet Aina, Milara Javier, Frías Soledad, Cortijo Julio, Armengot Miguel

机构信息

Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Universitari Bellvitge, 08907 Barcelona, Spain.

Institut d'Investigació Biomèdica (IDIBELL), 08908 Barcelona, Spain.

出版信息

J Clin Med. 2023 Feb 9;12(4):1391. doi: 10.3390/jcm12041391.

DOI:10.3390/jcm12041391
PMID:36835929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9965377/
Abstract

(1) Background: Factors influencing the quality of life (QoL) of patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) are poorly understood. We set out to determine the predictive factors on patients' QoL using the Sino-Nasal Outcome Test-22 (SNOT-22); (2) Methods: An ambispective analysis of data from patients diagnosed with CRSwNP in our institution. All the patients underwent a nasal polyp biopsy and completed the SNOT-22 questionnaire. Demographic and molecular data as well as the SNOT-22 scores were collected. Patients were classified in six subgroups considering the presence of asthma, non-steroidal drugs (NSAID) intolerance and corticosteroid resistance; (3) Results: The mean SNOT-22 score was 39. Considering the clinical parameters, the SNOT-22 value was significantly associated with NSAID intolerance ( = 0.04) and the endoscopic polyp score ( = 0.04). A high SNOT-22 value was also correlated with high tissue eosinophilia ( = 0.01) and high IL-8 expression; (4) Conclusions: Eosinophilia, IL-8 expression and NSAID intolerance can be used as predictors of worse QoL in patients with CRSwNP.

摘要

(1) 背景:影响伴有鼻息肉的慢性鼻-鼻窦炎(CRSwNP)患者生活质量(QoL)的因素尚不清楚。我们旨在使用鼻鼻窦结局测试-22(SNOT-22)来确定患者生活质量的预测因素;(2) 方法:对在我们机构被诊断为CRSwNP的患者的数据进行前瞻性和回顾性分析。所有患者均接受鼻息肉活检并完成SNOT-22问卷。收集人口统计学和分子数据以及SNOT-22评分。根据是否存在哮喘、非甾体类药物(NSAID)不耐受和糖皮质激素抵抗将患者分为六个亚组;(3) 结果:SNOT-22平均评分为39分。考虑临床参数,SNOT-22值与NSAID不耐受(P = 0.04)和内镜下息肉评分(P = 0.04)显著相关。高SNOT-22值也与高组织嗜酸性粒细胞增多(P = 0.01)和高白细胞介素-8表达相关;(4) 结论:嗜酸性粒细胞增多、白细胞介素-8表达和NSAID不耐受可作为CRSwNP患者生活质量较差的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/edec1dfe7b24/jcm-12-01391-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/dfe22db48cb6/jcm-12-01391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/533df0b31454/jcm-12-01391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/edec1dfe7b24/jcm-12-01391-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/dfe22db48cb6/jcm-12-01391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/533df0b31454/jcm-12-01391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd36/9965377/edec1dfe7b24/jcm-12-01391-g003.jpg

相似文献

1
Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps.伴有鼻息肉的慢性鼻-鼻窦炎患者生活质量的分子和临床预测指标
J Clin Med. 2023 Feb 9;12(4):1391. doi: 10.3390/jcm12041391.
2
Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.奥马珠单抗治疗难治性鼻息肉和轻度哮喘患者的效果:一项多中心回顾性研究。
Am J Rhinol Allergy. 2021 Jul;35(4):516-524. doi: 10.1177/1945892420972326. Epub 2020 Nov 5.
3
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.美泊利珠单抗改善伴有鼻息肉的重度慢性鼻-鼻窦炎患者的健康相关生活质量和疾病症状:SYNAPSE 研究的心理测量学和疗效分析。
J Patient Rep Outcomes. 2023 Jan 20;7(1):4. doi: 10.1186/s41687-023-00543-5.
4
Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.慢性鼻-鼻窦炎无鼻息肉、有鼻息肉或阿司匹林性加重呼吸道疾病患者的生活质量与鼻息肉大小之间的关联
J Clin Med. 2020 Mar 28;9(4):925. doi: 10.3390/jcm9040925.
5
Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.度普利尤单抗治疗与内镜鼻窦手术治疗伴有鼻息肉的慢性鼻-鼻窦炎的疗效比较。
Int Forum Allergy Rhinol. 2022 Aug;12(8):986-995. doi: 10.1002/alr.22951. Epub 2022 Jan 10.
6
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.度普利尤单抗治疗未得到控制的伴有鼻息肉的重度慢性鼻-鼻窦炎和 NSAID-ERD 临床诊断患者的疗效和安全性:两项随机安慰剂对照 3 期临床试验的结果。
Allergy. 2022 Apr;77(4):1231-1244. doi: 10.1111/all.15067. Epub 2021 Oct 1.
7
Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps.联合口服和局部皮质类固醇治疗慢性鼻-鼻窦炎伴鼻息肉患者疗效的预测因素。
Int Forum Allergy Rhinol. 2019 Dec;9(12):1436-1442. doi: 10.1002/alr.22431. Epub 2019 Oct 14.
8
5-Item sino-nasal outcome test and 22-item sino-nasal outcome test relationship with endoscopic and radiologic scores in chronic rhinosinusitis with nasal polyps.5 项鼻窦结局测试和 22 项鼻窦结局测试与鼻息肉慢性鼻窦炎的内镜和影像学评分的关系。
Ann Allergy Asthma Immunol. 2024 Mar;132(3):363-367. doi: 10.1016/j.anai.2023.11.011. Epub 2023 Nov 19.
9
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps.伴有鼻息肉的慢性鼻窦炎中炎症生物标志物与疾病控制之间的相关性
Int Forum Allergy Rhinol. 2024 Jul;14(7):1195-1205. doi: 10.1002/alr.23319. Epub 2024 Jan 24.
10
SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences.SNOT-22 基聚类在非鼻息肉型慢性鼻-鼻窦炎中的表现出不同的表型和预后差异。
Int Forum Allergy Rhinol. 2018 Jul;8(7):797-805. doi: 10.1002/alr.22101. Epub 2018 Feb 13.

本文引用的文献

1
[The expression and role of interleukin-8 in chronic rhinosinusitis].[白细胞介素-8在慢性鼻-鼻窦炎中的表达及作用]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Aug;35(8):765-768. doi: 10.13201/j.issn.2096-7993.2021.08.020.
2
EPOS2020: a major step forward.EPOS2020:向前迈出的一大步。
Rhinology. 2020 Feb 1;58(1):1. doi: 10.4193/Rhin20.401.
3
Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps.慢性鼻息肉鼻窦炎长期复发的预测标志物。
Am J Otolaryngol. 2020 Jan-Feb;41(1):102286. doi: 10.1016/j.amjoto.2019.102286. Epub 2019 Sep 4.
4
Differences in Expression of Inflammatory Mediator in Mucosal and Polyp Tissue between Chronic Rhinosinusitis and Recurrent Chronic Rhinosinusitis.慢性鼻窦炎与复发性慢性鼻窦炎患者黏膜及息肉组织中炎症介质表达的差异
Open Access Maced J Med Sci. 2019 May 31;7(11):1733-1738. doi: 10.3889/oamjms.2019.341. eCollection 2019 Jun 15.
5
The presence of eosinophil aggregates correlates with increased postoperative prednisone requirement.嗜酸性粒细胞聚集的出现与术后泼尼松需求量增加相关。
Laryngoscope. 2019 Apr;129(4):794-799. doi: 10.1002/lary.27693. Epub 2018 Dec 28.
6
NSAID hypersensitivity - recommendations for diagnostic work up and patient management.非甾体抗炎药超敏反应——诊断检查及患者管理建议
Allergo J Int. 2018;27(4):114-121. doi: 10.1007/s40629-018-0064-0. Epub 2018 May 25.
7
Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population.中国人群复发性鼻息肉炎症内型的多变量分析。
Rhinology. 2018 Sep 1;56(3):216-226. doi: 10.4193/Rhin17.240.
8
SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences.SNOT-22 基聚类在非鼻息肉型慢性鼻-鼻窦炎中的表现出不同的表型和预后差异。
Int Forum Allergy Rhinol. 2018 Jul;8(7):797-805. doi: 10.1002/alr.22101. Epub 2018 Feb 13.
9
Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial.与单独局部使用皮质类固醇相比,长期低剂量克拉霉素联合治疗对中国慢性鼻-鼻窦炎无额外疗效:一项随机对照试验。
Int Forum Allergy Rhinol. 2018 Jan;8(1):8-14. doi: 10.1002/alr.22041. Epub 2017 Nov 30.
10
Chronic rhinosinusitis in Asia.亚洲慢性鼻-鼻窦炎。
J Allergy Clin Immunol. 2017 Nov;140(5):1230-1239. doi: 10.1016/j.jaci.2017.09.009. Epub 2017 Oct 5.